ID27547A - Turunan kuinolin - Google Patents

Turunan kuinolin

Info

Publication number: ID27547A
Authority: ID; Indonesia
Prior art keywords: kuinolin; kuinolin down
Prior art date: 1998-07-15

Application number

IDW20010360A

Other languages

English (en)

Inventor

Anders Bjork

Stig Jonsson

Tomas Fex

Gunnar Hedlund

Original Assignee

Active Biotech Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-07-15

Filing date

1999-07-14

Publication date

2001-04-12

1999-07-14 Application filed by Active Biotech Ab filed Critical Active Biotech Ab

2001-04-12 Publication of ID27547A publication Critical patent/ID27547A/id

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Diabetes (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Rheumatology (AREA)
Pulmonology (AREA)
Dermatology (AREA)
Emergency Medicine (AREA)
Obesity (AREA)
Pain & Pain Management (AREA)
Hematology (AREA)
Endocrinology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Quinoline Compounds (AREA)

IDW20010360A 1998-07-15 1999-07-14 Turunan kuinolin ID27547A (id)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE9802550A SE9802550D0 (sv)	1998-07-15	1998-07-15	Quinoline derivatives

Publications (1)

Publication Number	Publication Date
ID27547A true ID27547A (id)	2001-04-12

Family

ID=20412094

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDW20010360A ID27547A (id)	1998-07-15	1999-07-14	Turunan kuinolin

Country Status (30)

Country	Link
EP (1)	EP1097139B1 (id)
JP (1)	JP4082865B2 (id)
KR (1)	KR100551611B1 (id)
CN (1)	CN1114597C (id)
AP (1)	AP1425A (id)
AT (1)	ATE229005T1 (id)
AU (1)	AU745915B2 (id)
BR (1)	BR9912104B1 (id)
CA (1)	CA2334718C (id)
DE (1)	DE69904333T2 (id)
DK (1)	DK1097139T3 (id)
EE (1)	EE04276B1 (id)
ES (1)	ES2187176T3 (id)
HR (1)	HRP20010038A2 (id)
HU (1)	HUP0103634A3 (id)
ID (1)	ID27547A (id)
IL (1)	IL140009A0 (id)
IS (1)	IS2187B (id)
NO (1)	NO317545B1 (id)
NZ (1)	NZ508924A (id)
OA (1)	OA11580A (id)
PL (1)	PL200147B1 (id)
PT (1)	PT1097139E (id)
RU (1)	RU2213734C2 (id)
SE (1)	SE9802550D0 (id)
TR (1)	TR200100086T2 (id)
UA (1)	UA70944C2 (id)
WO (1)	WO2000003992A1 (id)
YU (1)	YU1401A (id)
ZA (1)	ZA200007493B (id)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE0002320D0 (sv) *	1999-10-25	2000-06-21	Active Biotech Ab	Malignant tumors
AU1532802A (en)	2000-10-12	2002-04-22	Merck & Co Inc	Aza- and polyaza-naphthalenyl-carboxamides useful as hiv integrase inhibitors
EP1326865B1 (en)	2000-10-12	2009-05-06	Merck & Co., Inc.	Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
WO2003077857A2 (en)	2002-03-15	2003-09-25	Merck & Co., Inc.	N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7- carboxamides useful as hiv integrase inhibitors
SE0201778D0 (sv) *	2002-06-12	2002-06-12	Active Biotech Ab	Process for the manufacture of quinoline derivatives
US8314124B2 (en)	2004-02-06	2012-11-20	Active Biotech Ab	Crystalline salts of quinoline compounds and methods for preparing them
SE0400235D0 (sv)	2004-02-06	2004-02-06	Active Biotech Ab	New composition containing quinoline compounds
SE0401578D0 (sv) *	2004-06-18	2004-06-18	Active Biotech Ab	Novel compounds
BRPI0617477A2 (pt)	2005-10-19	2011-07-26	Teva Pharma	mistura de partÍculas cristalinas de laquinimod sàdica, composiÇço, processo de cristalizaÇço de laquinimod sàdica, laquinimod sàdica, e, processo para produzir uma composiÇço farmacÊutica
CN101466379B (zh)	2006-06-12	2012-10-31	泰华制药工业有限公司	稳定的拉喹莫德的制剂
WO2009082471A1 (en)	2007-12-20	2009-07-02	Teva Pharmaceutical Industries, Ltd.	Stable laquinimod preparations
AU2009288108B2 (en)	2008-09-03	2013-10-17	Teva Pharmaceutical Industries, Ltd.	2-oxo-1,2-dihydro-quinoline modulators of immune function
BR112012002124A2 (pt)	2009-07-30	2015-09-15	Teva Pharma	tratamento da doença de crohn com laquinimode.
WO2011019375A1 (en)	2009-08-10	2011-02-17	Teva Pharmaceutical Industries Ltd.	Treatment of bdnf-related disorders using laquinimod
KR20130006640A (ko)	2010-03-03	2013-01-17	테바 파마슈티컬 인더스트리즈 리미티드	라퀴니모드를 이용한 루푸스 신장염의 치료
EA201290860A1 (ru)	2010-03-03	2013-04-30	Тева Фармасьютикал Индастриз Лтд.	Лечение ревматоидного артрита комбинацией лаквинимода и метотрексата
AU2011274496B2 (en)	2010-07-09	2016-03-10	Teva Pharmaceutical Industries Ltd.	Deuterated N-ethyl-N-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, salts and uses thereof
KR20130065728A (ko)	2010-10-14	2013-06-19	임뮤나르 에이비	Ahr 활성화제로서의 1,2-디히드로-4-히드록시-2-옥소-퀴놀린-3-카르복사닐리드
SG11201401330YA (en)	2011-10-12	2014-05-29	Teva Pharma	Treatment of multiple sclerosis with combination of laquinimod and fingolimod
WO2013116657A1 (en)	2012-02-03	2013-08-08	Teva Pharmaceutical Industries Ltd.	USE OF LAQUINIMOD FOR TREATING CROHN'S DISEASE PATIENTS WHO FAILED FIRST-LINE ANTI-TNFα THERAPY
MX2014009889A (es)	2012-02-16	2014-11-13	Teva Pharma	N-etil-n-fenil-1,2-dihidro-4,5-di-hidroxi-1-metil-2-oxo-3-quinoli ncarboxamida, preparacion y usos de los mismos.
TW201350467A (zh)	2012-05-08	2013-12-16	Teva Pharma	Ｎ－乙基－４－羥基－１－甲基－５－（甲基（２，３，４，５，６－五羥基己基）胺基）－２－側氧－ｎ－苯基－１，２－二氫喹啉－３－甲醯胺
TW201400117A (zh)	2012-06-05	2014-01-01	Teva Pharma	使用拉喹莫德治療眼發炎疾病
TW201410244A (zh)	2012-08-13	2014-03-16	Teva Pharma	用於治療ｇａｂａ媒介之疾病之拉喹莫德（ｌａｑｕｉｎｉｍｏｄ）
EA201590788A1 (ru)	2012-11-07	2015-12-30	Тева Фармасьютикал Индастриз Лтд.	Аминные соли лахинимода
JP2016514162A (ja)	2013-03-14	2016-05-19	テバファーマシューティカルインダストリーズリミティド	ラキニモドナトリウムの結晶およびその製造のための改善された方法
HK1231413A1 (zh)	2014-04-29	2017-12-22	Teva Pharmaceutical Industries Ltd.	用於治疗具有高残疾状况的复发-缓解型多发性硬化症(rrms)的患者的拉喹莫德
JP2023527782A (ja) *	2020-05-21	2023-06-30	ステムシナジーセラピューティクス，インク．	Ｎｏｔｃｈ阻害剤及びその使用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IE52670B1 (en) *	1981-03-03	1988-01-20	Leo Ab	Heterocyclic carboxamides,compositions containing such compounds,and processes for their preparation
GB9108547D0 (en) *	1991-04-22	1991-06-05	Fujisawa Pharmaceutical Co	Quinoline derivatives
DE4120646A1 (de) *	1991-06-22	1992-12-24	Bayer Ag	7-isoindolinyl-chinolon- und naphthyridoncarbonsaeure-derivate
SE469368B (sv) *	1991-10-09	1993-06-28	Kabi Pharmacia Ab	Ny anvaendning av linomide foer tillverkning av laekemedel foer behandling av multiple sclerosis (ms)
CN1063686A (zh) *	1992-03-12	1992-08-19	华西医科大学药物研究所	用活性酯法合成维司力农
SE9201076L (sv) *	1992-04-06	1993-10-07	Shimon Slavin	Användningen av gamla läkemedel för behandling av diabetes
JPH07224040A (ja) *	1994-02-07	1995-08-22	Fujisawa Pharmaceut Co Ltd	キノリン誘導体
GB9404378D0 (en) *	1994-03-07	1994-04-20	Fujisawa Pharmaceutical Co	Quinoline derivatives
SE9400809D0 (sv) *	1994-03-10	1994-03-10	Pharmacia Ab	New use of quinoline-3-carboxamide compounds
SE9400810D0 (sv) *	1994-03-10	1994-03-10	Pharmacia Ab	New use of Quinoline-3-carboxamide compounds
GB2290786A (en) *	1994-06-30	1996-01-10	Fujisawa Pharmaceutical Co	Quinoline derivatives

1998
- 1998-07-15 SE SE9802550A patent/SE9802550D0/xx unknown
1999
- 1999-07-14 ES ES99935261T patent/ES2187176T3/es not_active Expired - Lifetime
- 1999-07-14 CA CA002334718A patent/CA2334718C/en not_active Expired - Fee Related
- 1999-07-14 PL PL345389A patent/PL200147B1/pl unknown
- 1999-07-14 WO PCT/SE1999/001271 patent/WO2000003992A1/en not_active Ceased
- 1999-07-14 JP JP2000560099A patent/JP4082865B2/ja not_active Expired - Fee Related
- 1999-07-14 HR HR20010038A patent/HRP20010038A2/hr not_active Application Discontinuation
- 1999-07-14 DK DK99935261T patent/DK1097139T3/da active
- 1999-07-14 UA UA2000127137A patent/UA70944C2/uk unknown
- 1999-07-14 AP APAP/P/2001/002040A patent/AP1425A/en active
- 1999-07-14 KR KR1020007014281A patent/KR100551611B1/ko not_active Expired - Fee Related
- 1999-07-14 OA OA1200100012A patent/OA11580A/en unknown
- 1999-07-14 TR TR2001/00086T patent/TR200100086T2/xx unknown
- 1999-07-14 YU YU1401A patent/YU1401A/sh unknown
- 1999-07-14 AU AU50775/99A patent/AU745915B2/en not_active Ceased
- 1999-07-14 NZ NZ508924A patent/NZ508924A/xx not_active IP Right Cessation
- 1999-07-14 AT AT99935261T patent/ATE229005T1/de not_active IP Right Cessation
- 1999-07-14 HU HU0103634A patent/HUP0103634A3/hu unknown
- 1999-07-14 PT PT99935261T patent/PT1097139E/pt unknown
- 1999-07-14 RU RU2001104344/04A patent/RU2213734C2/ru not_active IP Right Cessation
- 1999-07-14 EP EP99935261A patent/EP1097139B1/en not_active Expired - Lifetime
- 1999-07-14 EE EEP200100007A patent/EE04276B1/xx not_active IP Right Cessation
- 1999-07-14 ID IDW20010360A patent/ID27547A/id unknown
- 1999-07-14 DE DE69904333T patent/DE69904333T2/de not_active Expired - Lifetime
- 1999-07-14 IL IL14000999A patent/IL140009A0/xx not_active IP Right Cessation
- 1999-07-14 BR BRPI9912104-2A patent/BR9912104B1/pt not_active IP Right Cessation
- 1999-07-14 CN CN99808597A patent/CN1114597C/zh not_active Expired - Fee Related
2000
- 2000-12-05 IS IS5753A patent/IS2187B/is unknown
- 2000-12-14 ZA ZA200007493A patent/ZA200007493B/en unknown
2001
- 2001-01-12 NO NO20010210A patent/NO317545B1/no unknown

Also Published As

Publication number	Publication date
IS5753A (is)	2000-12-05
EP1097139A1 (en)	2001-05-09
JP2002520396A (ja)	2002-07-09
NO20010210L (no)	2001-03-15
CA2334718C (en)	2006-11-21
AP1425A (en)	2005-06-06
DK1097139T3 (da)	2002-12-30
HK1035716A1 (en)	2001-12-07
CN1309640A (zh)	2001-08-22
PT1097139E (pt)	2003-04-30
IS2187B (is)	2006-12-15
HRP20010038A2 (en)	2001-12-31
BR9912104B1 (pt)	2010-07-13
AP2001002040A0 (en)	2001-03-31
AU5077599A (en)	2000-02-07
RU2213734C2 (ru)	2003-10-10
HUP0103634A3 (en)	2002-03-28
PL200147B1 (pl)	2008-12-31
KR100551611B1 (ko)	2006-02-13
NO20010210D0 (no)	2001-01-12
DE69904333D1 (de)	2003-01-16
DE69904333T2 (de)	2003-10-16
WO2000003992A1 (en)	2000-01-27
AU745915B2 (en)	2002-04-11
KR20010071491A (ko)	2001-07-28
ZA200007493B (en)	2001-06-19
EP1097139B1 (en)	2002-12-04
PL345389A1 (en)	2001-12-17
CA2334718A1 (en)	2000-01-27
SE9802550D0 (sv)	1998-07-15
ATE229005T1 (de)	2002-12-15
UA70944C2 (uk)	2004-11-15
ES2187176T3 (es)	2003-05-16
JP4082865B2 (ja)	2008-04-30
IL140009A0 (en)	2002-02-10
CN1114597C (zh)	2003-07-16
TR200100086T2 (tr)	2001-05-21
YU1401A (sh)	2003-10-31
EE200100007A (et)	2002-06-17
OA11580A (en)	2004-07-01
NO317545B1 (no)	2004-11-15
HUP0103634A2 (hu)	2002-02-28
EE04276B1 (et)	2004-04-15
NZ508924A (en)	2002-09-27
BR9912104A (pt)	2001-05-02

Publication	Publication Date	Title
ID29066A (id)	2001-07-26	Turunan fenilglisina
ID27423A (id)	2001-04-05	Turunan kuinolin
DE69937850D1 (de)	2008-02-14	Hautablationslaser
DE59914158D1 (de)	2007-03-08	Metallocenmonohalogenide
DE69904211D1 (de)	2003-01-09	Polyalkoxylierte naphtopyrans
DE59911453D1 (de)	2005-02-17	Aktivkohlefilter
ID23234A (id)	2000-03-30	Turunan-turunan benzosulfona
DE59912371D1 (de)	2005-09-08	Gleitschalungsfertiger
DE69835302D1 (de)	2006-08-31	Tintenbehälternachfüllsystem
DE59901560D1 (de)	2002-07-04	Retrograder tibianagel
ID27484A (id)	2001-04-12	Turunan adenosina
DE69901661D1 (de)	2002-07-11	Fahrzeugnutzsitz
DE69936094D1 (de)	2007-06-28	Banknotenabtaster
DE59907306D1 (de)	2003-11-13	Fadenchangierung
DE59906931D1 (de)	2003-10-16	Exzenterzahnradgetriebe
DE59911683D1 (de)	2005-04-07	Fahrzeugschliessanlage
DE69902034D1 (de)	2002-08-08	Lattenkollimator
DE69901068D1 (de)	2002-05-02	Estersynthese
DE69902880D1 (de)	2002-10-17	Resonanzumwandlerschaltung
DE69811890D1 (de)	2003-04-10	Einzellenkalorimeter
DE69901852D1 (de)	2002-07-25	Perfluorodioxolen
DE59908968D1 (de)	2004-04-29	Benzoylpyridazine
DE59913393D1 (de)	2006-06-08	Fadenchangierung
DE69827358D1 (de)	2004-12-09	Weglenkungsverfahren
DE69902306D1 (de)	2002-09-05	Schwellwertventil